Amesite Inc. (AMST) Accelerates NurseMagic Sales with 95% Faster Enterprise Onboarding

Yahoo

02-03-2025

We recently compiled a list of the . In this article, we are going to take a look at where Amesite Inc. (NASDAQ:AMST) stands against the other AI stocks.
Just as the AI industry was catching up with the launch of the DeepSeek AI R1 model in January, sources divulged that the Hangzhou-based company is planning to release the R2 model as early as possible. The company was previously aiming to launch the R2 model in May.
DeepSeek expects the R2 model to exhibit better coding and reasoning capabilities in multiple languages. The R1 model, which was built cost-effectively using relatively less powerful GPUs, triggered a $1 trillion sell-off in US and European markets.
The speculation around the R2 model could potentially drive further volatility in America's AI landscape as investors question the narrative that US-based AI companies require hundreds of billions of dollars to develop AI systems.
"The launch of DeepSeek's R2 model could be a pivotal moment in the AI industry. DeepSeek's success at creating cost-effective AI models would likely spur companies worldwide to accelerate their own efforts ... breaking the stranglehold of the few dominant players in the field."
We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey's database of over 1000 hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A computer screen showcasing Artificial Intelligence and Machine Learning algorithms at work.
Amesite Inc. (NASDAQ:AMST) uses proprietary AI in its NurseMagic tool to streamline documentation workflow, improve patient communication, and save time for nurses and caregivers. Their HIPAA-compliant B2C and B2B solutions are helping to enhance operational efficiency, uplift care quality, and boost overall financial performance in the home care, hospice, and healthcare segments.
On February 25th, Amesite Inc. (NASDAQ:AMST) announced the success of its automated sales flow for its enterprise solution, NurseMagic for Teams. The company claims that the new purchase flow has reduced the time to close an enterprise sale by 95%, as enterprise clients can complete their NurseMagic subscription in minutes. The result is higher sales conversion and technology adoption alongside lower audit risks and negative reviews for clients, as they now have the capability to onboard teams immediately on the platform.
'Speed matters in enterprise sales, especially in healthcare, where time saved translates directly to better patient care. With our successful, automated sales flow, healthcare organizations are onboarding employees onto the NurseMagic™ app in record time, ensuring their teams can start experiencing efficiency gains immediately.'
Overall AMST ranks 8th on our list of AI stocks that investors likely missed. While we acknowledge the potential of AMST as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMST but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: and .
Disclosure: None. This article is originally published at Insider Monkey.